{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:05:04Z","timestamp":1763661904746,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006193","name":"Glenn Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31500928"],"award-info":[{"award-number":["31500928"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005224","name":"National Center for Immunization and Respiratory Diseases","doi-asserted-by":"publisher","award":["2016HXKF04"],"award-info":[{"award-number":["2016HXKF04"]}],"id":[{"id":"10.13039\/100005224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008753","name":"Shanghai Key Laboratory of Orthopaedic Implants","doi-asserted-by":"publisher","award":["2016ZDKF03"],"award-info":[{"award-number":["2016ZDKF03"]}],"id":[{"id":"10.13039\/501100008753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2014M562597"],"award-info":[{"award-number":["2014M562597"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008949","name":"Injury Prevention Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.bbrc.2017.08.033","type":"journal-article","created":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T03:30:35Z","timestamp":1503113435000},"page":"172-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel mechanism of pre-transplant insulin resistance contributing to post-transplant complications: Cyclosporin A-induced O-GlcNAcylation"],"prefix":"10.1016","volume":"492","author":[{"given":"Xinghua","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5433-9235","authenticated-orcid":false,"given":"Ziwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.08.033_bib1","first-page":"1162","article-title":"Cyclosporine improves outcome in high-risk cadaveric renal allograft recipients","volume":"16","author":"Van Buren","year":"1984","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.bbrc.2017.08.033_bib2","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1476-5381.2011.01700.x","article-title":"Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent","volume":"165","author":"Hausenloy","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2017.08.033_bib3","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/j.1600-6143.2012.04077.x","article-title":"Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantation","volume":"12","author":"Parekh","year":"2012","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.bbrc.2017.08.033_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.transproceed.2013.10.060","article-title":"Insulin resistance as a risk factor for new-onset diabetes after kidney transplantation","volume":"46","author":"Tokodai","year":"2014","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.bbrc.2017.08.033_bib5","first-page":"140","article-title":"Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantation","volume":"71","author":"Ramesh Prasad","year":"2009","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.bbrc.2017.08.033_bib6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.transproceed.2013.03.009","article-title":"New-onset diabetes after transplantation: assessment of risk factors and clinical outcomes","volume":"45","author":"Cotovio","year":"2013","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.bbrc.2017.08.033_bib7","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.4239\/wjd.v6.i10.1132","article-title":"Dysglycemia after renal transplantation: definition, pathogenesis, outcomes and implications for management","volume":"6","author":"Langsford","year":"2015","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.bbrc.2017.08.033_bib8","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1016\/j.transproceed.2010.10.008","article-title":"Risk factors for the development of new-onset diabetes mellitus in a living related renal transplant program","volume":"42","author":"Bora","year":"2010","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.bbrc.2017.08.033_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCRESAHA.110.224675","article-title":"O-GlcNAc signaling in the cardiovascular system","volume":"107","author":"Ngoh","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2017.08.033_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbagen.2009.08.008","article-title":"Dysregulation of the nutrient\/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease","volume":"1800","author":"Lefebvre","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2017.08.033_bib11","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00329.2005","article-title":"Hexosamines, insulin resistance, and the complications of diabetes: current status","volume":"290","author":"Buse","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2017.08.033_bib12","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1039\/b704905f","article-title":"O-GlcNAc modification in diabetes and Alzheimer's disease","volume":"3","author":"Dias","year":"2007","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.bbrc.2017.08.033_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/14789450.2013.820536","article-title":"Protein O-GlcNAcylation in diabetes and diabetic complications","volume":"10","author":"Ma","year":"2013","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.bbrc.2017.08.033_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-291X(02)00200-0","article-title":"Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase","volume":"293","author":"Konrad","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2017.08.033_bib15","doi-asserted-by":"crossref","unstructured":"Tokodai, K., Amada, N., Haga, I., Takayama, T., Nakamura, A., Kashiwadate, T., Insulin resistance as a risk factor for new-onset diabetes after kidney transplantation, Transplant. Proc. 46 537\u2013539.","DOI":"10.1016\/j.transproceed.2013.10.060"},{"key":"10.1016\/j.bbrc.2017.08.033_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/tri.12026","article-title":"Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation","volume":"26","author":"Nagaraja","year":"2013","journal-title":"Transpl. Int."},{"key":"10.1016\/j.bbrc.2017.08.033_bib17","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/TP.0b013e3181f1543c","article-title":"Association of metabolic syndrome with development of new-onset diabetes after transplantation","volume":"90","author":"Bayer","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.bbrc.2017.08.033_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fendo.2014.00141","article-title":"Diabetes Mellitus in the Transplanted Kidney","volume":"5","author":"Peev","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.bbrc.2017.08.033_bib19","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0026-895X(24)12316-4","article-title":"Diabetogenic effect of Cyclosporin A is mediated by interference with mitochondrial function of pancreatic B-Cells","volume":"60","author":"D\u00fcfer","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2017.08.033_bib20","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2337\/diab.42.12.1753","article-title":"Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients","volume":"42","author":"Krentz","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2017.08.033_bib21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/diacare.14.10.867","article-title":"Effects of cyclosporin A and low dosages of steroid on posttransplantation diabetes in kidney transplant recipients","volume":"14","author":"Yamamoto","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbrc.2017.08.033_bib22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/mol.107.040782","article-title":"Activation of the dual-leucine-zipper-bearing kinase and induction of beta-cell apoptosis by the immunosuppressive drug cyclosporin A","volume":"73","author":"Plaumann","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2017.08.033_bib23","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1464-5491.2012.03617.x","article-title":"Cellular and physiological mechanisms of new-onset diabetes mellitus after solid organ transplantation","volume":"29","author":"Dong","year":"2012","journal-title":"Diabet. Med."},{"key":"10.1016\/j.bbrc.2017.08.033_bib24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0026-895X(24)12316-4","article-title":"Diabetogenic effect of cyclosporin A is mediated by interference with mitochondrial function of pancreatic B-cells","volume":"60","author":"Dufer","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2017.08.033_bib25","first-page":"301","article-title":"Cracking the O-GlcNAc code in metabolism, trends endocrinol","volume":"24","author":"Ruan","year":"2013","journal-title":"Metab"},{"key":"10.1016\/j.bbrc.2017.08.033_bib26","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1126\/science.1058714","article-title":"Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc","volume":"291","author":"Wells","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2017.08.033_bib27","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1073\/pnas.152346899","article-title":"Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia","volume":"99","author":"McClain","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2017.08.033_bib28","doi-asserted-by":"crossref","first-page":"10022","DOI":"10.1074\/jbc.M207787200","article-title":"Insulin resistance of glycogen synthase mediated by o-linked N-acetylglucosamine","volume":"278","author":"Parker","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2017.08.033_bib29","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2337\/db09-1086","article-title":"Increased expression of beta-N-acetylglucosaminidase in erythrocytes from individuals with pre-diabetes and diabetes","volume":"59","author":"Park","year":"2010","journal-title":"Diabetes"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17315784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17315784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:13:56Z","timestamp":1757762036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X17315784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0006291X17315784"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.08.033","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel mechanism of pre-transplant insulin resistance contributing to post-transplant complications: Cyclosporin A-induced O-GlcNAcylation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}